The Form 4 filing, an SEC report of insider stock activity, lists Julie Winkler as senior managing director and chief commercial officer at CME Group. The filing date was November 2, 2026, which was also the date of the sale.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-02 |
| Date of Latest Transaction | 2026-11-02 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 10,079 |
| Price | $305.15 |
| Total Transaction Value | $3,075,606.85 |
| Insider | |
| Ticker Symbol | CME |
| Company | CME GROUP INC. |
| Insider Name | Winkler Julie |
| Insider Title | Sr MD Chief Commercial Officer |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 21,482 |
| Position Size Change | 31.93% |
| Filing | |
| Filing Date | 2026-11-02 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale, reported under SEC transaction code S. Julie Winkler sold 10,079 shares in one transaction. The available details do not state where the shares were sold.
What was the average price of the transaction?
The reported average sale price was $305.15 per share.
How did this transaction affect the insider's holdings?
She sold 10,079 shares and reported 21,482 shares owned afterward. Those figures imply a balance of 31,561 shares before the sale. The shares sold made up 31.93% of that earlier balance.
What's the total transaction value?
The total transaction value was $3,075,606.85. That amount covers the 10,079 shares sold in the single reported transaction.
Are there any special circumstances around this transaction?
The available transaction information did not identify a special arrangement. Footnote text was not available, so any further terms or explanations remain unknown. The details do not state why she sold or establish whether other circumstances affected the sale.
For research purposes only; not investment advice.